CervoMed (CRVO) Return on Sales (2022 - 2025)
CervoMed's Return on Sales history spans 9 years, with the latest figure at 23.95% for Q3 2025.
- For Q3 2025, Return on Sales fell 2150.0% year-over-year to 23.95%; the TTM value through Sep 2025 reached 4.15%, down 297.0%, while the annual FY2024 figure was 1.67%, 61.0% down from the prior year.
- Return on Sales for Q3 2025 was 23.95% at CervoMed, down from 3.55% in the prior quarter.
- Across five years, Return on Sales topped out at 174.39% in Q3 2022 and bottomed at 23.95% in Q3 2025.
- The 4-year median for Return on Sales is 1.03% (2024), against an average of 16.01%.
- The largest annual shift saw Return on Sales tumbled -17611bps in 2023 before it grew 11bps in 2024.
- A 4-year view of Return on Sales shows it stood at 174.39% in 2022, then tumbled by -101bps to 0.95% in 2023, then tumbled by -227bps to 3.1% in 2024, then plummeted by -672bps to 23.95% in 2025.
- Per Business Quant, the three most recent readings for CRVO's Return on Sales are 23.95% (Q3 2025), 3.55% (Q2 2025), and 2.55% (Q1 2025).